In vivo: ↓ hepatic injury, steatosis, fibrosis, oxidative stress and inflammation; inhibited TXNIP and NLRP3. In vitro: suppressed NLRP3 activation, restored lipid metabolism. Here, TXNIP is linked to steatosis.